Photodynamic Therapy Devices Market Size - By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis), End-use (Hospitals, Dermatology Clinics) & Global Forecast, 2024 – 2032

Photodynamic Therapy Devices Market Size - By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis), End-use (Hospitals, Dermatology Clinics) & Global Forecast, 2024 – 2032

Photodynamic Therapy Devices Market Size

Photodynamic Therapy Devices Market size was valued at USD 779.1 million in 2023 and is estimated to expand at 8.3% CAGR from 2024 to 2032. Photodynamic therapy devices (PTD) are medical instruments designed for a therapeutic technique that uses light and a photosensitizing chemical substance to treat various medical conditions, including certain types of cancer and certain skin conditions. Furthermore, photodynamic therapy devices have gained traction in dermatology for treating skin conditions such as actinic keratosis, acne, and certain types of skin cancer.
 

Moreover, cancer, which was responsible for almost 10 million deaths in 2020, constituting nearly one in six deaths globally, stands as a prominent cause of mortality worldwide as per the World Health Organization. The prevalent types include breast, prostate, colon, rectum, and lung cancer, which is estimated to reach USD 86.5 billion by 2032. Thus, with the increasing incidence of various types of cancer, there has been a growing interest in PDT as a treatment modality. This has led to the development of PDT devices specifically designed for cancer therapy, particularly for skin cancers like basal cell carcinoma and squamous cell carcinoma.
 

Photodynamic Therapy Devices Market Trends

Photodynamic therapy devices play a crucial role in the treatment of certain cancer cases. It is commonly employed in the treatment of skin cancers, such as basal cell carcinoma and squamous cell carcinoma. It is also used for certain precancerous lesions and other superficial cancers. The choice of PDT depends on the type, location, and extent of the cancer.
 

• Photodynamic therapy devices offer a selective and targeted treatment approach. It is particularly advantageous for surface-level tumors and lesions. The photosensitizing agent is preferentially absorbed by the abnormal cells, and upon exposure to light of a specific wavelength, it induces a reaction that selectively destroys the targeted cells.
   
• Its minimally invasive nature compared to some traditional cancer treatments. It involves the application of a photosensitizing agent, which can be administered topically or systemically, followed by localized light activation. This can result in fewer side effects and a quicker recovery for patients.
   

Photodynamic Therapy Devices Market Analysis

Based on product, the photodynamic therapy devices industry is segmented into diode lasers and disposable fiber optic light delivery devices. The diode lasers segment is poised for significant growth at a CAGR of 8.2% during the forecast period.
 

• Diode lasers are commonly used as light sources in PDT devices. Market trends often involve continuous technological advancements to improve the efficiency, precision, and safety of diode lasers. These advancements may include developments in laser diode design, wavelength options, and power output.
   
• There has been a trend towards the development of more portable and compact PDT devices. This shift is driven by the desire for greater convenience in clinical settings and an increasing focus on outpatient and in-office procedures. Diode lasers, known for their compact size and versatility, align well with this trend.

Based on application, the photodynamic therapy devices market is segmented into cancer, actinic keratosis, acne, psoriasis, and other applications. The cancer segment accounted for 37.3% of the market share in 2023.
 

• Ongoing clinical trials and research studies exploring the effectiveness of PDT in various cancer types contribute to the evolving landscape of PDT applications. Positive outcomes from these studies may further drive the adoption of photodynamic therapy devices in cancer treatment.
   
• The integration of PDT into combination therapies, which may include surgery, radiation, or chemotherapy, has been a notable trend. Combining PDT with other treatment modalities allows for a synergistic approach, potentially improving overall treatment outcomes.
   

The photodynamic therapy devices market by end-use is categorized into hospitals, dermatology clinics, and other end-users. The hospitals segment dominated around USD 331.5 million revenue size in 2023.
 

• Photodynamic therapy devices are commonly integrated into the treatment offerings of hospitals, particularly those equipped with specialized departments such as oncology and dermatology. The integration of PDT into hospital services contributes to the overall growth of the photodynamic therapy market.
   
• The adoption of advanced medical technologies, including PDT devices with improved light sources and delivery systems, contributes to the revenue generated in the hospitals segment. Hospitals are key players in acquiring and utilizing cutting-edge medical equipment.
   
• The multidisciplinary nature of hospitals, encompassing various medical specialties and departments, supports the integration of PDT into different treatment regimens. This approach allows for collaborative efforts in cancer treatment and dermatological interventions.

North America photodynamic therapy devices market size held over USD 315.9 million in 2023.
 

• North America has witnessed a rise in the incidence of skin cancers, including basal cell carcinoma and squamous cell carcinoma. PDT, with its effectiveness in treating certain skin cancers, has likely seen increased adoption in the region.
   
• Collaborations between PDT device manufacturers, healthcare institutions, and research organizations in North America contribute to market expansion. These partnerships may focus on research and development, clinical trials, and the commercialization of advanced PDT technologies.
   
• The regulatory environment in North America, including approvals from the U.S. food and drug administration (FDA) and other regulatory bodies, plays a crucial role in shaping the market. Compliance with regulatory standards is essential for market entry and growth.
   

Photodynamic Therapy Devices Market Share

The photodynamic therapy devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Boston Scientific Corporation, Coherent Corporation, Cutera Inc. among others have a notable presence in the market.
 

Photodynamic Therapy Devices Market Companies

Some of the eminent market participants operating in the photodynamic therapy devices industry include

• Biolitec AG
• Boston Scientific Corporation
• Candela Corporation
• Coherent Corporation
• Cutera Inc.
• Excel Lasers
• IRIDEX Corporation
• Lumibird Medical
• Modulight USA Inc.
• ShangHai Apolo Medical Technology Co.,Ltd.
   

Photodynamic Therapy Devices Industry News

• In June 2022, LUMIBIRD established Lumibird Medical India in Mumbai to drive sales of Quantel Medical and Ellex products in the Indian market. The subsidiary focused on offering ophthalmic lasers, ultrasound platforms, and advanced equipment for diagnosis and treatment, reflecting LUMIBIRD's commitment to expanding its presence in India's healthcare sector.
   

The photodynamic therapy devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product

• Diode lasers
• Disposable fiber optic light delivery devices

Market, By Application

• Cancer
• Actinic keratosis
• Acne
• Psoriasis
• Other applications

Market, By End-use

• Hospitals
• Dermatology clinics
• Other end-users

The above information has been provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa